NeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. It has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices. Its products include DPNCheck, Quell and ADVANCE System. DPNCheck is a quantitative nerve conduction test that is used to evaluate peripheral neuropathies, such as Diabetic peripheral neuropathy (DPN). Quell a wearable device for symptomatic relief and management of chronic pain. ADVANCE System is a platform for the performance of nerve conduction studies. DPNCheck customers include managed care organizations, endocrinologists, podiatrists and primary care physicians. ADVANCE System customers include occupational health, primary care, internal medicine and many others.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
Industry Peers | NTUS | |
---|---|---|
Summary | ||
Company Profile | NeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that... | Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. It provides product solutions... Go to NTUS summary |
52-Week Change | VS. INDUSTRY | 21.81% |
Market Cap | VS. INDUSTRY | $1.1B |
Beta | VS. INDUSTRY | 0.2 |
Dividend Yield | VS. INDUSTRY | -- |
P/E (TTM, GAAP) | VS. INDUSTRY | 87.69x |
Data as of | ||
Fundamentals | ||
Total Revenue (TTM) | VS. INDUSTRY | $478.3M |
Profit Margin | VS. INDUSTRY | 2.65% |
Earnings Growth (5 year, GAAP) | VS. INDUSTRY | -21.35% |
Revenue Growth (TTM) | VS. INDUSTRY | 13.55% |
Data as of |
Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.